NIH Awards Allele with Grant for the Development of Nanoantibody Therapies for Treating Sepsis

SAN DIEGO--(BUSINESS WIRE)--$Cell #Ablynx--The National Institute of General Medical Sciences of NIH has awarded a Small Business Innovative Research grant to Allele Biotechnology and Pharmaceuticals to develop new single-domain nanoantibody (nAb) therapies for the treatment of sepsis. Sepsis and septic shock are among the leading causes of death in intensive care units (ICUs). The global incidence of sepsis has increased over the years, while the mortality rate, which can reach over 60% for septic shock, has